Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00368628 · ClinicalTrials.gov registry record · Phase 2
Continuous Positive Airway Pressure for the Treatment of Stroke
A Phase 2 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
- 55
- Enrollment target
NCT00368628 is a Phase 2 study that has completed, run by Yale University. The registered enrollment target is 55 participants.
The verdict
NCT00368628, a Phase 2 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 55 participants
- Enrollment target
Study Summary
New stroke therapies are needed. This study seeks to provide the preliminary data needed to plan a future study that will evaluate the efficacy of using continuous positive airway pressure (CPAP) to treat stroke patients who have sleep apnea. Our goal is to use this therapy to reduce stroke symptom severity.
Interventions
- PROCEDURE continuous positive airway pressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2004-11 |
| Est. Completion | 2008-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00368628
The ClinicalTrials.gov registry entry for NCT00368628 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which continuous positive airway pressure is the first listed.
NCT00368628 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00368628 about?
NCT00368628 is a clinical study titled "Continuous Positive Airway Pressure for the Treatment of Stroke". New stroke therapies are needed. This study seeks to provide the preliminary data needed to plan a future study that will evaluate the efficacy of using continuous positive airway pressure (CPAP) to treat stroke patients who have sleep apnea. Our goal is to use this therapy to reduce stroke symptom ...
What is the current status of trial NCT00368628?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 55 participants. The study started on 2004-11. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00368628?
The interventions under investigation include: continuous positive airway pressure (PROCEDURE).
Who is sponsoring clinical trial NCT00368628?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.